WO2025088378 - COMPOSITIONS AND METHODS FOR CANCER TREATMENT USING CHIMERIC VIRAL VECTORS
National phase entry:
Publication Number
WO/2025/088378
Publication Date
01.05.2025
International Application No.
PCT/IB2024/000596
International Filing Date
25.10.2024
Title **
[English]
COMPOSITIONS AND METHODS FOR CANCER TREATMENT USING CHIMERIC VIRAL VECTORS
[French]
COMPOSITIONS ET MÉTHODES POUR TRAITER LE CANCER À L'AIDE DE VECTEURS VIRAUX CHIMÉRIQUES
Applicants **
INFINITOPES LIMITED
Inventors
CHINNAKANNAN, Senthil
KWOK, Jonathan
LEE, Lian, Ni
BOKUM, Annemieke, Ten
MARINOU, Spyridoula
TONG, Orion
Priority Data
63/593,110
25.10.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 7176 | |
| EPO | Filing, Examination, Granting | 146694 | |
| Japan | Filing, Examination, Granting | 5003 | |
| South Korea | Filing, Examination, Granting | 9695 | |
| USA | Filing, Examination, Granting | 44340 |
Total:
212,908
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are compositions and methods for the treatment of cancer in a human subject comprising administration of a recombinant chimeric vector. The recombinant chimeric vector comprise a cancer-specific CD8+ T cell epitope which may induce an inflating memory CD8+ and/or CD4+ T cell response in the subject.[French]
L'invention concerne des compositions et des méthodes pour traiter le cancer chez un sujet humain comprenant l'administration d'un vecteur chimérique recombinant. Le vecteur chimérique recombinant comprend un épitope de lymphocyte T CD8+ spécifique du cancer qui peut induire, en réponse, une inflation des lymphocytes T CD8 + et/ou CD4+ mémoire chez le sujet.